Cargando…

Practical insights into chronic management of hepatic Wilson’s disease

Wilson’s disease (WD) is a rare inherited disorder of human copper metabolism, with an estimated prevalence of 1:30000-1:50000 and a broad spectrum of hepatic and neuropsychiatric manifestations. In healthy individuals, the bile is the main route of elimination of copper. In WD patients, copper accu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lynch, Erica Nicola, Campani, Claudia, Innocenti, Tommaso, Dragoni, Gabriele, Forte, Paolo, Galli, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125272/ https://www.ncbi.nlm.nih.gov/pubmed/35663095 http://dx.doi.org/10.12998/wjcc.v10.i14.4334

Ejemplares similares

Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectives
por: Lynch, Erica Nicola, et al.
Publicado: (2022)

Main factors influencing long-term outcomes of liver transplantation in 2022
por: Fuochi, Elisa, et al.
Publicado: (2023)

Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey
por: Innocenti, Tommaso, et al.
Publicado: (2022)

Wilson's disease: Revisiting an old friend
por: Lucena-Valera, Ana, et al.
Publicado: (2021)

Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA
por: Sekiba, Kazuma, et al.
Publicado: (2018)

Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases
por: Kawanaka, Miwa, et al.
Publicado: (2021)

Higher volume growth rate is associated with development of worrisome features in patients with branch duct-intraductal papillary mucinous neoplasms
por: Innocenti, Tommaso, et al.
Publicado: (2022)

Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows
por: Guarino, Maria, et al.
Publicado: (2018)

Discontinuation of antiviral therapy in chronic hepatitis B patients
por: Medas, Renato, et al.
Publicado: (2021)

Challenges in the discontinuation of chronic hepatitis B antiviral agents
por: Kaewdech, Apichat, et al.
Publicado: (2021)

Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice
por: Marascio, Nadia, et al.
Publicado: (2022)

Antiviral treatment for chronic hepatitis B: Safety, effectiveness, and prognosis
por: Wu, Ya-Li, et al.
Publicado: (2019)

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021)

Chronic hepatitis B in pregnant women: Current trends and approaches
por: Belopolskaya, Maria, et al.
Publicado: (2021)

Chronic hepatitis B: New potential therapeutic drugs target
por: Leowattana, Wattana, et al.
Publicado: (2022)

Sarcopenia in chronic viral hepatitis: From concept to clinical relevance
por: Coelho, Marta Paula Pereira, et al.
Publicado: (2023)

Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients
por: Lee, Hye Won, et al.
Publicado: (2016)

Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patients
por: Guo, Jiang, et al.
Publicado: (2021)

Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease
por: Ladino, Marco, et al.
Publicado: (2017)

Gastroparesis: New insights into an old disease
por: Usai-Satta, Paolo, et al.
Publicado: (2020)

Update on the management and treatment of viral hepatitis
por: Almeida, Patricia Holanda, et al.
Publicado: (2021)

Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings
por: Said, Zeinab Nabil Ahmed, et al.
Publicado: (2022)

Current evidence on the management of hepatitis B in pregnancy
por: Maraolo, Alberto Enrico, et al.
Publicado: (2018)

Management of hepatitis B and C in special population
por: Kulkarni, Anand V, et al.
Publicado: (2021)

Impact of modern antiviral therapy of chronic hepatitis B and C on clinical outcomes of liver disease
por: Khoo, Tiffany, et al.
Publicado: (2021)

Early-onset colorectal cancer: Current insights and future directions
por: Wu, Claudia Wing-Kwan, et al.
Publicado: (2022)

Radiofrequency ablation in the management of primary hepatic and biliary tumors
por: Hendriquez, Richard, et al.
Publicado: (2022)

Progression and status of antiviral monitoring in patients with chronic hepatitis B: From HBsAg to HBV RNA
por: Liu, Ya-Yun, et al.
Publicado: (2018)

Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger?
por: Lenci, Ilaria, et al.
Publicado: (2020)

Direct antiviral agents in hepatitis C virus related liver disease: Don’t count the chickens before they’re hatched
por: Compagnoni, Stella, et al.
Publicado: (2021)

Chronic hepatitis B-associated liver disease in the context of human immunodeficiency virus co-infection and underlying metabolic syndrome
por: Amponsah-Dacosta, Edina, et al.
Publicado: (2020)

Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-α treatment and retreatment
por: Yin, Guo-Qing, et al.
Publicado: (2022)

Renal transplant recipient seizure practical management
por: Sawhney, Harpreet, et al.
Publicado: (2020)

Management of hepatitis C in children and adolescents during COVID-19 pandemic
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2020)

Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasia
por: Ielasi, Luca, et al.
Publicado: (2023)

Historical changes in surgical strategy and complication management for hepatic cystic echinococcosis
por: A, Ji-De, et al.
Publicado: (2023)

Long-term liver allograft fibrosis: A review with emphasis on idiopathic post-transplant hepatitis and chronic antibody mediated rejection
por: Vij, Mukul, et al.
Publicado: (2022)

Expanding antiviral therapy indications for HBeAg-negative chronic hepatitis B patients with normal ALT and positive HBV DNA
por: Zhou, Jing, et al.
Publicado: (2022)

Drug-induced liver injury and COVID-19: A review for clinical practice
por: Ortiz, Gabriela Xavier, et al.
Publicado: (2021)

Impact of hepatitis B virus infection on hepatic metabolic signaling pathway
por: Shi, Yi-Xian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t8baiv7th632apd39uoc2kdk7t